SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-029334
Filing Date
2023-08-14
Accepted
2023-08-14 16:02:06
Documents
51
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vyne-20230630.htm   iXBRL 10-Q 827862
2 EX-10.1 orallicense-forsecfiling.htm EX-10.1 434853
3 EX-31.1 vyne-20230630xexx311.htm EX-31.1 9607
4 EX-31.2 vyne-20230630xexx312.htm EX-31.2 9601
5 EX-32.1 vyne-20230630xexx321.htm EX-32.1 5245
6 EX-32.2 vyne-20230630xexx322.htm EX-32.2 5240
12 image_1.jpg GRAPHIC 43608
  Complete submission text file 0001628280-23-029334.txt   4760704

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vyne-20230630.xsd EX-101.SCH 30281
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vyne-20230630_cal.xml EX-101.CAL 48854
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vyne-20230630_def.xml EX-101.DEF 163558
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vyne-20230630_lab.xml EX-101.LAB 396226
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vyne-20230630_pre.xml EX-101.PRE 265405
45 EXTRACTED XBRL INSTANCE DOCUMENT vyne-20230630_htm.xml XML 421635
Mailing Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38356 | Film No.: 231169602
SIC: 2834 Pharmaceutical Preparations